A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Northwell Health Walk Raises Record-setting $1.06M to Advance Health Care in Our Communities

More than 4,000 people comprising patients, families, community members and Northwell Health employees came together on May 21 to help raise more than $1.06 million for local hospital programs, breaking a record previously set in 2019. Supporters stepped up across five Northwell Health Walk locations – Jones Beach, Port Jefferson, Riverhead, Westchester and Staten Island – to raise funds in their respective communities for women and babies, cancer treatment, and child and adolescent behavioral health at Northwell Health hospitals.

“Every year, thousands of people across the region join the Northwell Health Walk to affirm their belief in Northwell’s commitment to raise health in our communities,” said Brian Lally, senior vice president and chief development officer for Northwell Health. “It’s extraordinary to see the outpouring of support that grows each and every year.”

A new mom’s journey inspires at Jones Beach

At Jones Beach, the festive day included appearances by Mr. & Mrs. Met and the Islanders’ Sparky the Dragon, a kids zone and face painting. Walkers warmed up to support mental healthcare programs and resources for pregnant and postpartum women at the Katz Institute for Women’s Health (KIWH) as well as plans for a new child and adolescent behavioral health hub at Cohen Children’s Medical Center.

Also participating in the Jones Beach Walk was Claire Byrnes of Northport, NY, who shared her pregnancy and childbirth story. After years of being told it would be impossible to carry a baby, Ms. Byrnes sought the help of KIWH obstetrician-gynecologist Stephanie McNally, MD, who helped her become pregnant. Dr. McNally worked with Cara Pessel, MD, a KIWH maternal-fetal specialist, to keep Mrs. Byrnes and the baby healthy. At 28 weeks, Mrs. Byrnes was admitted to the hospital with severe preeclampsia and extreme anxiety. Her son was born at three and a half pounds through an emergency delivery at 31 weeks and went home in less than two weeks. His grateful mother went home a few days later and continues to receive the help she needs for postpartum depression, anxiety and post-traumatic stress disorder through the Katz Institute.

“I am so grateful to my physicians at Northwell not only for making my dream of motherhood come true, but for their compassionate care in helping me cope with my postpartum mental health,” said Mrs. Byrnes, who was at the walk with her husband, John, and baby, Edward.  “This event is so important to raise funds so other women like me can have access to the expertise and resources they need to live healthy, fulfilled lives.”

Funds support the communities they serve

Across New York, funds raised at four other walks will support hospitals in their local communities. The Port Jefferson Walk supports the Fortunato Breast Cancer Center at Mather Hospital, and the East End/Riverhead Walk will help expand the breast health program and support the development of a comprehensive mother and baby unit at Peconic Bay Medical Center. Funds raised for Northern Westchester Hospital and Phelps Hospital will help with the purchase of sensory tools for young patients with autism and other challenges as well as support education and assistance programs for hospital team members. The Staten Island Walk supports the construction of the new Florina Cancer Center at Staten Island University Hospital.

The Walk began in 2010 as the “Every Woman Matters Walk,” inspired by the vision of philanthropists Iris and Saul Katz, whose commitment to high-quality health care continues to be felt throughout Northwell.  Since its inception, the Northwell Health Walk has raised more than $7 million and supports Northwell’s Outpacing the Impossible campaign, a comprehensive $1.4 billion fundraising effort that supports Northwell’s promise to the people it serves. The campaign’s objectives include improving hospitals and clinical programs, accelerating research and funding endowment.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy